What This Means for Patients who Use GLP-1s Health coverage varies a lot across different regions, providers, and plans
A., Myint, P
Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc
Do not leave the pen in direct sunlight or near heat sources like stoves or heaters, as this can damage the medication
So what they do, both of those drugs, they convert white fat to brown fat they increase thermogenesis of fat burning